RxGen, Inc. is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.
Looking for a particular RxGen employee's phone or email?
RxGen Questions
The RxGen annual revenue was $4 million in 2026.
Sven Korte is the Senior Director Research and Safety Assessment of RxGen.
6 people are employed at RxGen.
RxGen is based in Hamden, Connecticut.
The NAICS codes for RxGen are [54171, 5417, 54, 541, 541711].
The SIC codes for RxGen are [80, 28, 283].
Top RxGen Employees
-
Sven Korte
Senior Director Research and Safety Assessment at RxGen
Saint Kitts and Nevis21 -
11
-
Akeba Matthew
Senior Surgical Specialist at RxGen
Saint Kitts and Nevis
Related Companies
